Summary by Futu AI
ACEA PHARMACEUTICALS LIMITED FILED THE FOLLOWING DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON 21 FEBRUARY 2024 DISCLOSING THE REPURCHASE STATUS OF ITS SHARES. According to the report, the company conducted several share repurchases between December 19, 2023 and February 21, 2024, but did not write them off. The most recent repurchase took place on 21 February 2024 and repurchased 800,000 shares at a price of between HK$1.84 and HK$1.89 per share for a total cost of approximately HK$1,498,040. Since the adoption of the Ordinary Resolution, the total number of shares repurchased by the company on the Hong Kong Stock Exchange has reached 69,291,000 shares, representing 6.3737% of the shares issued at that time. The Company confirms that all repurchases are conducted in accordance with the provisions of the HKEx and have been formally authorized by the Board of Directors.